Literature DB >> 19555720

TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses.

Ildelfonso Vicente-Suarez1, Jason Brayer, Alejandro Villagra, Fengdong Cheng, Eduardo M Sotomayor.   

Abstract

Dendritic cells (DCs) differentiated in the presence of IL-10 preferentially induce regulatory T-cells and tolerance. Whether the tolerogenic properties displayed by these DCs (Tol-DCs) can be overcome has not been fully explored. Here we show for the first time that Tol-DCs express higher levels of TLR5 mRNA, but not TLR4 or TLR9 mRNA relative to DCs differentiated with GM-CSF and IL-4 (BM-DCs). In response to flagellin, a natural TLR-5 ligand, Tol-DCs produced IL-12 but not IL-10. Unlike Tol-DCs stimulated with LPS, which produce high levels of IL-10 and fail to generate a cognate inflammatory response in CD4(+) T-cells, flagellin-stimulated Tol-DCs promoted the differentiation of CD4(+) T cells with a T-helper 1 phenotype. The divergent T-cell outcomes induced by Tol-DCs in response to different TLR-ligands highlights not only their plasticity, but also points to TLR5 ligation as a potential strategy to overcome tolerance in environments that are otherwise conducive to immune unresponsiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555720      PMCID: PMC2758552          DOI: 10.1016/j.imlet.2009.06.007

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  21 in total

Review 1.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

Authors:  Abdelilah Wakkach; Nathalie Fournier; Valérie Brun; Jean-Philippe Breittmayer; Françoise Cottrez; Hervé Groux
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

Review 3.  Toll-like receptor control of the adaptive immune responses.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse.

Authors:  Katsuaki Sato; Naohide Yamashita; Naomi Yamashita; Masanori Baba; Takami Matsuyama
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

6.  Flagellin as a good carrier and potent adjuvant for Th1 response: study of mice immune response to the p27 (Rv2108) Mycobacterium tuberculosis antigen.

Authors:  Vincent Le Moigne; Georges Robreau; Wahib Mahana
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

7.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

8.  Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists.

Authors:  Stefan Fernandez; Purnima Jose; Margarita G Avdiushko; Alan M Kaplan; Donald A Cohen
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

9.  Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response.

Authors:  Arnaud Didierlaurent; Isabel Ferrero; Luc A Otten; Bertrand Dubois; Monique Reinhardt; Harald Carlsen; Rune Blomhoff; Shikuo Akira; Jean-Pierre Kraehenbuhl; Jean-Claude Sirard
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

10.  Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.

Authors:  J Kirberg; A Baron; S Jakob; A Rolink; K Karjalainen; H von Boehmer
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  24 in total

1.  TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.

Authors:  Nathan D Chamberlain; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; William Swedler; Arthur M Mandelin; Shiva Shahrara
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  Flagellin as an adjuvant: cellular mechanisms and potential.

Authors:  Steven B Mizel; John T Bates
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

3.  Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.

Authors:  Mohammad S Hossain; David L Jaye; Brian P Pollack; Alton B Farris; Malefa L Tselanyane; Ebenezer David; John D Roback; Andrew T Gewirtz; Edmund K Waller
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

4.  Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.

Authors:  Ki-Hye Kim; Young-Man Kwon; Young-Tae Lee; Hye Suk Hwang; Min-Chul Kim; Eun-Ju Ko; Bao-Zhong Wang; Fu-Shi Quan; Sang-Moo Kang
Journal:  Virology       Date:  2018-09-07       Impact factor: 3.616

5.  Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions.

Authors:  Agnieszka Jezierska; Irina A Kolosova; Alexander D Verin
Journal:  Curr Signal Transduct Ther       Date:  2011

6.  TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity.

Authors:  Degui Geng; Sabina Kaczanowska; Alexander Tsai; Kenisha Younger; Augusto Ochoa; Aaron P Rapoport; Sue Ostrand-Rosenberg; Eduardo Davila
Journal:  Cancer Res       Date:  2015-03-20       Impact factor: 12.701

7.  Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity.

Authors:  Olivier Renaudet; Gargi Dasgupta; Ilham Bettahi; Alda Shi; Anthony B Nesburn; Pascal Dumy; Lbachir BenMohamed
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

8.  Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis.

Authors:  Craig M Brackett; Bojidar Kojouharov; Jean Veith; Kellee F Greene; Lyudmila G Burdelya; Sandra O Gollnick; Scott I Abrams; Andrei V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

9.  Flagellin in fusion with human rotavirus structural proteins exerts an adjuvant effect when delivered with replicating but non-disseminating adenovectors through the intrarectal route.

Authors:  Aurélie Girard; Elodie Roques; Bernard Massie; Denis Archambault
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

10.  The MSHA strain of Pseudomonas aeruginosa activated TLR pathway and enhanced HIV-1 DNA vaccine immunoreactivity.

Authors:  Jue Hou; Yong Liu; Ying Liu; Yiming Shao
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.